FRI0020 Blocking the inhibitory CD94/NKG2A NK cell receptor with a novel ANTI-NKG2A MAB enhances the susceptibility of rheumatoid arthritis fibroblast-like synoviocytes (FLS) to NK cell-mediated cytotoxicity
Nielsen N., Galsgaard ED., Ahern D., Andersen M., Spee P., Feldmann M., Brennan F., Söderström K.